Alex Zhu
@alexzhuDO
Followers
483
Following
581
Statuses
100
So unbelievably excited. Can’t wait for this next chapter in my life! Thank you to ALL those at Michigan that have supported me. With a special shout-out to @gpalapa2 @wandering_gu @urooncsurgeon @arvinkgeorge @khkraft So thankful 🙏🏻Go Blue! And Go Huskies! 💙💛💜
Congratulations to our newest member of the Urologic Oncology family! We are thrilled to welcome @alexzhuDO to @UroOnc where we will continue expanding our knowledge and shaping the future of urologic oncology @UWMedicine 👏👏
14
1
120
RT @spsutkaMD: Applying for a @UroOnc fellowship this year and interested in learning more about the @uwurology SUO Fellowship? We are exci…
0
5
0
0
0
3
Unbelievably proud of these two for matching at their top choice 🥇for SUO @UroOnc Fellowship These guys are awesome clinicians, researchers, coresidents, and have become two of my best friends. CONGRATS! @TrinerDaniel 🌲@StanfordUrology
@ApoorvDhir 🐏 @UNCurology
5
5
66
RT @PGrivasMDPhD: Congrats to amazing @SteveBlinka @MeeraChappidi for @ASCO YIA & their amazing mentors @HsiehLab @DanLinMD We are proud @u…
0
10
0
Further proof that AS is safe + preferred for favorable risk pCA (cohort: 90% GG1) Authors argue re importance of confirmatory biopsy…23% of pts upgraded at this point But in practice we often avoid confirmatory biopsy for GG1 pCA, esp with negative mpMRI What to do? 😮
Just out in @JAMA_current: Long-term outcomes of prostate cancer AS in PASS. Since 2008: ➡️2,155 patients with median 7.2 year f/u. ➡️21 patients have developed metastatic disease ➡️3 prostate cancer-related deaths Track each patient 👇
1
0
12
RT @wandering_gu: Beaming with joy, pride, and admiration as @samsimsal is awarded the @AmerUrological Gold Cystoscope. He is an absolutely…
0
20
0
Wow! Our clinical SUO fellow Alley May @may_alley just won 🥇place at the AUA Early Career Investigator showcase. What a HUGE honor!!
1
4
41
RT @BenPockros: 🤩🤩 it’s @alexzhuDO on the main stage #AUA24 talking about an RCT he led in residency 💫
0
3
0
🙌🏻 to the most supportive coresidents, attendings and department!
How amazing is our 🌟 of @UMUroResidency chief @alexzhuDO giving a plenery on RCT on optimal hydrodistention technique #AUA24 ✅ degree of sx relief 🟰 across pressures, duration, and # of distentions ➡️ Should we opt for low P, short duration?
1
0
19
At the #AUA24 Great Debate @CatherineSNamMD bringing the 🔥🔥 AUS should be performed as a sole procedure for patients with ED and incontinence after EBRT 👀audience vote!!
0
3
19
RT @UMUroResidency: It’s officially #AUA24 week! So proud of our (10!!) residents, who will be busy in San Antonio 🌵 Come and support th…
0
15
0
@FloMaxBowman @_backtableUro @lindsayahampson @GMBadalato This was awesome! @FloMaxBowman so many great tips for being a senior resident #pinecone
0
1
4
3) provide substance to the limitations section. Don’t just say that “this project was limited by its retrospective design”. Expand on this — why does your retrospective design impact your data and the interpretation of the data?
1
0
0
1) don’t be afraid to highlight the unique aspects of your research (ex. “for the first time we have shown that…”). Too often, authors will embed this statement deep within the paper. Instead, blatantly say this in the introduction, letter to editor, and abstract 📣
1
0
0